Impact of smokeless tobacco on cardiovascular disease risk in a Nigerian metropolitan city

Author:

Oguanobi Nelson . I.1,Chijioke Chioli . P.1,Ghasi Samuel . I.1,Nubila Nkoyo I.1,Okolo Caleb . C.1

Affiliation:

1. University of Nigeria

Abstract

Abstract Background: The use of smokeless tobacco products (STP) as a substitute for tobacco smoking is driving increasing consumption of these products especially in developing countries. Objective: The study sought to make comparison of cardiovascular risk profile between chronic STP users and suitable matched tobacco-naïve controls. Method: This is a preliminary report from the cross sectional part of a two-arm prospective study of Smokeless Tobacco Products Composition and Exposure Exposure Outcome in Enugu metropolis. Consecutively recruited current Smokeless tobacco users aged 18 years and above, residing in selected communities in Enugu metropolis were recruited for the study. Age and sex matched non tobacco users from same localities as the study subjects served as controls. Written informed consent to participate in the study was obtained from all study participants. All participants were screened to obtain data on medical history, demographic, clinical, laboratory, and electrocardiographic evaluation. Result: Data from 54 STP-users and 54 non-STP-users (mean age 56.58 ± 8.15 years) were analyzed. Anthropometric parameters were similar in both groups. The STP-users had higher erect and supine blood pressure indices as well greater postural drop in systolic blood pressure. The occurrence of diabetes mellitus (20.37% versus 5.56%) and hypertension (25.93%; 11.11%) were significantly more in the STP-users than in the non-user population, (p = 0.02192 and 0.04751 respectively). Electrocardiographic evaluation showed significantly increased QTc and dispersions of P-wave, QRS and QT intervals as well as reduced PR interval in STP users. Electrocardiographic abnormalities observed in STP users include left ventricular hypertrophy, left atrial enlargement, ST-segment elevation, short PR interval and long QTc. Conclusion: Use of smokeless tobacco products is associated with increased risk and burden of diabetes mellitus and hypertensive heart disease. Electrocardiographic findings linked to STP-use in this study are features consistent with arrhythmia, ventricular repolarization abnormality, myocardial hypertrophy and ischaemia, suggesting that smokeless tobacco products are not safe substitutes for tobacco smoking.

Publisher

Research Square Platform LLC

Reference37 articles.

1. Smokeless Tobacco Products. (2023). Including Dip, Snuff, Snus, and Chewing Tobacco. United States Food and Drug Administration.

2. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels;Stepanov I;Nicotine & Tobacco Research,2008

3. Nicotine content and delivery across tobacco products;Djordjevic MV;Handbook Of Experimental Pharmacology,2009

4. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis;Boffetta P;Bmj,2009

5. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum;Benowitz NL;Clinical Pharmacology And Therapeutics,1988

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3